Westside Investment Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-235
Closed -$50 773
2021
Q1
$50 Sell
235
-300
-56% -$56.4K ﹤0.01% 373
2020
Q4
$34.6K Hold
535
0.1% 112
2020
Q3
$29.2K Hold
535
0.01% 112
2020
Q2
$36.8K Hold
535
0.02% 87
2020
Q1
$26.3K Buy
+535
New +$56.7K 0.02% 111
2019
Q2
$42 Buy
+245
New +$42.4K ﹤0.01% 338
2018
Q4
$22.9K Hold
235
0.01% 367
2018
Q3
$39.3K Hold
235
0.01% 278
2018
Q2
$33.1K Hold
235
0.01% 331
2018
Q1
$24.9K Hold
235
0.01% 355
2017
Q4
$30.9K Sell
235
-50
-18% -$5.88K 0.02% 335
2017
Q3
$31.2K Sell
285
-50
-15% -$5.36K 0.02% 325
2017
Q2
$33.5K Buy
335
+50
+18% +$5.38K 0.02% 310
2017
Q1
$33.4K Buy
285
+50
+21% +$6.13K 0.02% 289
2016
Q4
$28K Buy
+235
New +$28.3K 0.02% 242

Other funds holding GWPH

Westside Investment Management's GWPH Position: Q2 2021 in Review

Westside Investment Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 235 shares — an estimated $50 sold.

Westside Investment Management first reported a position in GWPH in Q4 2016 and held it in 15 quarters. The position peaked at $39.3K in Q3 2018. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Westside Investment Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Westside Investment Management sold 235 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $50.
  • Westside Investment Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2016 and held it in 15 quarters.
  • Westside Investment Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $39.3K in Q3 2018.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Westside Investment Management's 13F filing for Q2 2021, filed 28 Jul 2021.